检索

期
标题
作者
卷 17, 编号 3 (2020)
Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19
Chazova I., Blinova N., Nevzorova V., Zhernakova J., Savenkov M., Oshchepkova E., Ostroumova O., Kisliak O., Boytsov S.
PDF
(Rus)
卷 6, 编号 3 (2009)
Dynamics of blood pressure, heart rate variability and QTc in patients with metabolic syndrome on the selective betablockerand biguanide therapy.
Ryabykina G., Shishova T., Laptev D., Mychka V., Lyutikova L., Kozhemyakina E., Shchedrina E., Sobolev A., Chazova I.
卷 15, 编号 4 (2018)
Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes
Kovalenko F., Skibitsky V., Fendrikova A.
PDF
(Rus)
卷 15, 编号 2 (2018)
Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion
Litvin A., Elfimova E., Chazova I.
PDF
(Rus)
卷 14, 编号 3 (2017)
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
Chazova I., Zhernakova Y., Blinova N., Rogoza A.
PDF
(Rus)
卷 13, 编号 4 (2016)
The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
Ostroumova O., Garelik I., Karavashkina E.
PDF
(Rus)
卷 12, 编号 2 (2015)
The hardness of the vessel wall in patients with arterial hypertension
Ostroumova O., Kochetkov A., Kopchenov I., Guseva T., Bondarec O.
PDF
(Rus)
卷 11, 编号 1 (2014)
The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»)
Ostroumova O., Bondarets O., Guseva T.
PDF
(Rus)
卷 10, 编号 4 (2013)
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District
Chazova I., Trubacheva I., Zhernakova Y., Oshchepkova E., Serebriakova V., Kaveshnikov V., Karpov R.
卷 10, 编号 2 (2013)
Efficacy of irbesartan in arterial hypertension and metabolic syndrome
Ostroumova O., Zykova A., Polosova T., Bondarets O.
卷 10, 编号 1 (2013)
The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)
Chazova I., Chuchalin A., Zykov K., Ratova L.
卷 6, 编号 2 (2009)
HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association
卷 3, 编号 2 (2006)
Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom
Chazova I., Martynyuk T.
卷 2, 编号 1 (2005)
Kogda neobkhodimo nachinat' lechenie arterial'noy gipertonii s fiksirovannykh kombinatsiy? Novye tendentsii
Ostroumova O., Golovina O.
卷 2, 编号 1 (2005)
Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?
Shestakova M.
卷 1, 编号 1 (2004)
Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)
Chazova I.
卷 1, 编号 1 (2004)
Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey
Chikhladze N., Chazova I.
卷 18, 编号 1 (2021)
Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.
PDF
(Rus)
卷 17, 编号 3 (2020)
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.
PDF
(Rus)
卷 16, 编号 2 (2019)
Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity
Zhernakova J., Zheleznova E., Chazova I., Blinova N., Ivanov K., Starodubova A.
PDF
(Rus)
卷 16, 编号 4 (2019)
Consensus on patients with hyperuricemia and high cardiovascular risk treatment
Chazova I., Zhernakova J., Kisliak O., Nedogoda S., Podzolkov V., Oshchepkova E., Medvedeva I., Mironova O., Blinova N.
PDF
(Rus)
卷 15, 编号 4 (2018)
Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension
Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.
PDF
(Rus)
卷 15, 编号 1 (2018)
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results
Zhernakova Y., Chazova I., Oshchepkova E., Shalnova S., Konradi A., Rotar O., Yarovaya E., Shlyahto E., Boitsov S.
PDF
(Rus)
卷 15, 编号 1 (2018)
Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers
Ostroumova O., Kochetkov A.
PDF
(Rus)
卷 14, 编号 3 (2017)
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
Avalyan A., Kirillova M., Shitov V., Oshchepkova Y., Saidova M., Stenina M., Chazova I.
PDF
(Rus)
卷 14, 编号 2 (2017)
A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment
Temnikova E.
PDF
(Rus)
卷 13, 编号 3 (2016)
Prolonged release verapamil: application in clinical practice
Gaponova N., Abdrakhmanov V.
PDF
(Rus)
卷 12, 编号 1 (2015)
The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome
Skibickiy V., Fendrikova A., Skibickiy A., Syrotenko D.
PDF
(Rus)
卷 11, 编号 2 (2014)
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
Zhernakova Y., Chazova I.
PDF
(Rus)
卷 11, 编号 1 (2014)
Hypertension treatment features in perimenopausal women
Zhernakova Y., Chazova I.
PDF
(Rus)
卷 10, 编号 3 (2013)
Vliyanie raznykh skhem antigipertenzivnoy terapii s dostizheniem tselevykh znacheniy arterial'nogo davleniya na sostoyanie funktsii pochek i vnutripochechnoe sosudistoe soprotivlenie u bol'nykh sakharnym diabetom tipa 2
Koshel'skaya O., Zhuravleva O., Karpov R.
卷 10, 编号 3 (2013)
Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii
Shilov A.
卷 3, 编号 2 (2006)
Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii
Galyavich A.
卷 2, 编号 2 (2005)
Vozmozhnosti korrektsii endotelial'noy disfunktsii ingibitorami angiotenzinprevrashchayushchego fermenta
Gorokhovskaya G., Petina M., Akatova E., Aksenov I., Martynov A.
卷 1, 编号 2 (2004)
Samokontrol' arterial'nogo davleniya patsientami povyshaet priverzhennost' k lecheniyu arterial'noy gipertonii (nablyudenie 1 god)
Oshchepkova E., Tsagareishvili E., Rogoza A.
卷 1, 编号 2 (2004)
Pervye rezul'taty Rossiyskoy programmy po izucheniyu effektivnosti primeneniya akarbozy u patsientov s narushennoy tolerantnost'yu k glyukoze i arterial'noy gipertoniey (APREL')
Chazova I., Mychka V., Belenkov Y.
卷 17, 编号 4 (2020)
The place of fixed antihypertensive drugs in modern therapy of arterial hypertension
Pinchuk T., Orlova N.
PDF
(Rus)
卷 17, 编号 1 (2020)
Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up
Agaeva R., Danilov N., Shchcelkova G., Matchin Y., Chazova I.
PDF
(Rus)
卷 16, 编号 3 (2019)
Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article]
Blinova E., Sakhnova T., Chaykovskaya O., Saidova M., Ryabykina G.
PDF
(Rus)
卷 6, 编号 4 (2009)
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
Chazova I., Ostroumova O.
卷 15, 编号 1 (2018)
The place of intervention methods of treatment of patients with resistant hypertension in clinical practice
Agaeva R., Danilov N., Sagaydak O., Chazova I.
PDF
(Rus)
卷 14, 编号 1 (2017)
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
Zhernakova Y., Martyniuk T., Arkhipova O., Azimova M., Rogoza A., Chazova I.
PDF
(Rus)
卷 13, 编号 4 (2016)
Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension
Shchelkova G., Zairova A., Danilov N., Rogoza A., Chazova I.
PDF
(Rus)
卷 12, 编号 1 (2015)
The role of beta-blockers in the treatment of arterial hypertension: what do we know today
Zhernakova Y., Chazova I.
PDF
(Rus)
卷 12, 编号 2 (2015)
Heart rate in patients with arterial hypertension:a possible marker of high risk or independent therapeutic target?
Kobalava Z., Shavarova E.
PDF
(Rus)
卷 11, 编号 4 (2014)
Local rigidity of the walls of the carotid artery at the site of formation of atherosclerotic plaques in patients with arterial hypertension
Vakhovskaya T., Tripoten M., Pogorelova O., Balakhonova T., Loukianov M., Boytsov S.
PDF
(Rus)
卷 11, 编号 4 (2014)
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension
Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.
PDF
(Rus)
卷 11, 编号 2 (2014)
The benefits of candesartan usage in the treatment of arterial hypertension
Ostroumova O., Bondarets O., Guseva T.
PDF
(Rus)
卷 11, 编号 1 (2014)
Experience of treating hypertension in an outpatient setting: a clinical case
Agafonov A., Khozyainova N., Petruschenkova O.
PDF
(Rus)
卷 11, 编号 1 (2014)
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components
Zhernakova Y., Sharipova G., Chazova I.
PDF
(Rus)
卷 10, 编号 4 (2013)
Coagulogic risk factors of heart disease in the adult population of Tomsk
Dobrovolsky A., Titaeva E., Yarovaya E., Storozhilova A., Zhernakova Y., Oschepkova E., Panchenko E., Trubacheva I., Serebryakova V., Kaveshnikova V., Chazova I., Karpov R.
卷 10, 编号 2 (2013)
A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs
Titov V.
卷 2, 编号 1 (2005)
Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA)
Chazova I., Ratova L.
卷 1, 编号 1 (2004)
Gipotenzivnaya effektivnost' novoy lekarstvennoy formy metoprolola zamedlennogo vysvobozhdeniya u bol'nykh s arterial'noy gipertoniey
Belousov Y., Leonova M., Erofeeva S.
卷 1, 编号 1 (2004)
Arterial'naya gipertoniya i ishemicheskaya bolezn' serdtsa: poisk optimal'nykh podkhodov k lecheniyu (po rezul'tatam issledovaniya INVEST)
Chazova I.
卷 17, 编号 4 (2020)
Primary hyperaldosteronism as a possible cause of resistant arterial hypertension
Chikhladze N.
PDF
(Rus)
卷 17, 编号 1 (2020)
Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2
Chazova I., Shestakova M., Zhernakova Y., Markova T., Mazurina N., Yezhov M., Mironova O., Litvin A., Elfimova E., Blinova N., Sukhareva O., Ametov A., Akhmedzhanov N., Kislyak O., Kukharchuk V., Nedogoda S., Nebieridze D., Medvedev I., Mkrtumyan A., Podzolkov V.
PDF
(Rus)
卷 16, 编号 3 (2019)
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
Zhernakova J., Chazova I., Blinova N.
PDF
(Rus)
卷 16, 编号 3 (2019)
Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty
Ostroumova O., Cherniaeva M.
PDF
(Rus)
卷 15, 编号 4 (2018)
The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm
Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E.
PDF
(Rus)
卷 14, 编号 4 (2017)
Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension
Alekseeva T., Litvin A.
PDF
(Rus)
卷 14, 编号 2 (2017)
Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?
Martynyuk T., Chazova I.
PDF
(Rus)
卷 14, 编号 1 (2017)
The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension
Elfimova E., Rvacheva A., Tripoten M., Pogorelova O., Balakhonova T., Zykov K., Litvin A.
PDF
(Rus)
卷 13, 编号 3 (2016)
Application of advanced electrovectorcardiographic methods in the diagnosis of left ventricular hypertrophy on the basis of Uryupinsk central district hospital
Vishnyakova N., Ryabykina G., Sakhnova T., Blinova E., Kozhemiakina E., Volkov V.
PDF
(Rus)
卷 12, 编号 3 (2015)
Radiofrequency denervation of renal arteries. Myth or reality?
Grigin V., Danilov N., Matchin Y., Chazova I.
PDF
(Rus)
卷 12, 编号 1 (2015)
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
Zhernakova Y., Sharipova G., Chazova I.
PDF
(Rus)
卷 11, 编号 3 (2014)
The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects
Gilyarevsky S.
PDF
(Rus)
卷 11, 编号 3 (2014)
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
Baryshnikov G., Stepanova I., Kudryavtseva N.
PDF
(Rus)
卷 11, 编号 2 (2014)
The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk
Mordvinova E., Oschepkova E., Fedorovich A., Rogoza A.
PDF
(Rus)
卷 10, 编号 3 (2013)
Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
Mancia G., Fagard R.
卷 10, 编号 1 (2013)
Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension
Ostroumova O., Pervichko E.
卷 3, 编号 2 (2006)
Pri vsem bogatstve vybora drugoy al'ternativy net Issledovanie ETNA Plyus (ETNA v zhizni vracha polikliniki)
Chazova I., Ratova L.
卷 2, 编号 2 (2005)
Arterial'naya gipertoniya i tserebrovaskulyarnye narusheniya
Skvortsova V.
卷 1, 编号 2 (2004)
Kognitivnye funktsii u patsientov s arterial'noy gipertenziey: vliyanie gipotenzivnoy terapii
Ostroumova O., Desnitskaya I.
101 - 174 的 174 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##